Who Owns Cartesian Therapeutics Stock?
NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 29.45%
- Held by insiders
- 52.13%
- Institutional holders
- 127
- Institutions 29.5%
- Insiders 52.1%
- Public and other 18.4%
Who owns Cartesian Therapeutics stock?
Institutional investors own about 29.5% of Cartesian Therapeutics's shares, spread across 127 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 52.13% of RNAC.
The largest institutional holders are Squarepoint Ops LLC (7.45%), Blackrock Inc. (2.71%) and 683 Capital Management LLC (2.15%). Together, the top 10 institutions control 20.6% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their RNAC positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RNAC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Squarepoint Ops LLC | 2.25M | 7.45% | +0.7% |
| Blackrock Inc. | 819.24K | 2.71% | +36.7% |
| 683 Capital Management LLC | 650.00K | 2.15% | +97.0% |
| Vanguard Capital Management LLC | 555.82K | 1.84% | +36.4% |
| FMR, LLC | 368.43K | 1.22% | -53.9% |
| Geode Capital Management, LLC | 356.52K | 1.18% | +35.2% |
| AQR Capital Management, LLC | 356.46K | 1.18% | +324.3% |
| Millennium Management Llc | 309.89K | 1.02% | +9.0% |
| Two Sigma Investments, LP | 296.29K | 0.98% | +77.1% |
| State Street Corporation | 249.21K | 0.82% | +24.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RNAC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 376.31K | 1.24% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 366.55K | 1.21% |
| iShares Trust-iShares Russell 2000 ETF | 333.54K | 1.10% |
| Janus Detroit Street Trust-Janus Henderson Small Cap Growth Alpha ETF | 195.16K | 0.65% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 169.73K | 0.56% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 144.04K | 0.48% |
| iShares Trust-iShares Russell 2000 Value ETF | 93.86K | 0.31% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 69.86K | 0.23% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 53.46K | 0.18% |
| iShares Trust-iShares Micro-Cap ETF | 43.83K | 0.14% |
Frequently asked questions
Who is the largest shareholder of Cartesian Therapeutics?
Squarepoint Ops LLC is the largest institutional shareholder of RNAC, owning 7.45% of shares outstanding (2.25M shares) as of its latest 13F filing.
What percentage of Cartesian Therapeutics is owned by institutions?
Institutions own about 29.5% of RNAC shares and 61.5% of the public float.
How much of Cartesian Therapeutics do insiders own?
Insiders, such as officers and directors, own about 52.13% of RNAC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.